Insulin glargine use and short-term incidence of breast cancer a four-year population-based observation

Acta Oncologica

Volumn 51, Issue 3, 2012, Pages 400-402

  Ljung, Rickard ^a,b   Talbäck, Mats ^a   Haglund, Bengt ^a   Jonasson, Junmei Miao ^b,c,f   Gudbjörnsdòttir, Soffia ^d,e,f   Steineck, Gunnar ^c  

^a NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^f National Diabetes Register   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE;

ADULT; AGED; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; FEMALE; HUMAN; INSULIN TREATMENT; LETTER; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN, LONG-ACTING; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 84859753534     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.624118     Document Type: Letter

References (5)

1. Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, Steineck G. Insulin glargine use and short-term incidence of malignancies - A population-based follow-up study in Sweden. Diabetologia 2009;52:1745-54.
2. Ljung R, Talback M, Haglund B, Jonasson JM, Gudbjornsdottir S, Steineck G. Insulin glargine use and shortterm incidence of malignancies - A three-year population-based observation. Acta. Oncol. 2011;50:685-93.
3. WHO Collaboration Centre for Drugs Statistics Methodology [Internet]. Oslo: WHOCC. [cited 2011 Aug 30]. Available from: http://www.whocc.no/atcddd/
4. Suissa S, Azoulay L, Dell'aniello S, Evans M, Vora J, Pollak M. Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia Epub 2011 May 26.
5. Mannucci E, Monami M, Balzi D, Cresci B, Melani C, Lamanna C, et al. Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 2010;33:1997-2003.